Key facts
- Notable investors include Zhengling Venture Capital, Hongying Capital.
- Status: Privately Held (backing).
- ·The complete investor list — 2 names
- ·Watchlist + deal alerts for JiDeKangMin
- ·The full record, as it builds
Funding rounds
No funding rounds for JiDeKangMin are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About JiDeKangMin
Manufacturer of biotechnology solutions intended for health and wellness enhancement purpose. The company develops products incorporating advanced bioactive compounds, precision formulation techniques, controlled fermentation processes, molecular stability optimization, quality assurance protocols, and scalable production systems, enabling healthcare providhealthcare providers and consumer markets improved nutritional efficacy, enhanced safety standards, consistent product performance, and reliable support for preventive and therapeutic applications across diverse biological and clinical environments.
- Sector
- Healthcare
- HQ
- Guangzhou, China
- Founded
- 2018
- Employees
- 28
- Website
- gdkongming.com/
- Ownership
- Privately Held (backing)
JiDeKangMin doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in JiDeKangMin shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on JiDeKangMin in its N-PORT filings yet. We sweep new filings monthly.